ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

New Research Projects Proposed For Immunology

September 30, 1977

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009